Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Annual change in eGFR in renal hypouricemia: a retrospective pilot study.
Sugihara S, Yamamoto Y, Teramoto K, Hamada T, Miyazaki S, Ogino K, Kuwabara M, Ohtahara A, Mizuta E, Ichida K, Endo Y, Minato H, Ninomiya H, Kato M, Yamamoto K, Hisatome I. Sugihara S, et al. Among authors: yamamoto y, yamamoto k. Clin Exp Nephrol. 2024 Oct 3. doi: 10.1007/s10157-024-02558-8. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 39361182
Hematuria in patients with renal hypouricemia.
Hisatome I, Tanaka Y, Ogino K, Shimoyama M, Hiroe K, Tsuboi M, Yamamoto Y, Hamada N, Kato T, Manabe I, Kinugawa T, Ohtahara A, Yoshida A, Shigemasa C, Takeda A, Sato R. Hisatome I, et al. Among authors: yamamoto y. Intern Med. 1998 Jan;37(1):40-6. doi: 10.2169/internalmedicine.37.40. Intern Med. 1998. PMID: 9510398 Free article.
Effects of azelnidipine on uric acid metabolism in patients with essential hypertension.
Miyazaki S, Hamada T, Hirata S, Ohtahara A, Mizuta E, Yamamoto Y, Kuwabara M, Nosaka Y, Igawa O, Ogino K, Kato M, Yoshida A, Ninomiya H, Cheng J, Moriwaki Y, Yamamoto K, Hisatome I. Miyazaki S, et al. Among authors: yamamoto y, yamamoto k. Clin Exp Hypertens. 2014;36(7):447-53. doi: 10.3109/10641963.2013.846359. Epub 2014 Jan 16. Clin Exp Hypertens. 2014. PMID: 24433018 Free article. Clinical Trial.
Apoptosis induced by an uromodulin mutant C112Y and its suppression by topiroxostat.
Utami SB, Mahati E, Li P, Maharani N, Ikeda N, Bahrudin U, Munemura C, Hosoyamada M, Yamamoto Y, Yoshida A, Nakayama Y, Higaki K, Nanba E, Ninomiya H, Shirayoshi Y, Ichida K, Yamamoto K, Hosoya T, Hisatome I. Utami SB, et al. Among authors: yamamoto y, yamamoto k. Clin Exp Nephrol. 2015 Aug;19(4):576-84. doi: 10.1007/s10157-014-1032-8. Epub 2014 Sep 20. Clin Exp Nephrol. 2015. PMID: 25239792
Plasma levels of uridine correlate with blood pressure and indicators of myogenic purine degradation and insulin resistance in hypertensive patients.
Hamada T, Mizuta E, Yanagihara K, Kaetsu Y, Sugihara S, Sonoyama K, Yamamoto Y, Kato M, Igawa O, Shigemasa C, Inokuchi T, Yamamoto T, Shimada T, Ohtahara A, Ninomiya H, Hisatome I. Hamada T, et al. Among authors: yamamoto y, yamamoto t. Circ J. 2007 Mar;71(3):354-6. doi: 10.1253/circj.71.354. Circ J. 2007. PMID: 17322634 Free article.
Status of uric acid management in hypertensive subjects.
Yamamoto Y, Matsubara K, Igawa G, Kaetsu Y, Sugihara S, Matsuura T, Ando F, Sonoyama K, Hamada T, Ogino K, Igawa O, Shigemasa C, Hisatome I. Yamamoto Y, et al. Hypertens Res. 2007 Jun;30(6):549-54. doi: 10.1291/hypres.30.549. Hypertens Res. 2007. PMID: 17664859
Effects of angiotensin II on the action potential durations of atrial myocytes in hypertensive rats.
Sonoyama K, Igawa O, Miake J, Yamamoto Y, Sugihara S, Sasaki N, Shimoyama M, Hamada T, Taniguchi S, Yoshida A, Ogino K, Shigemasa C, Hoshikawa Y, Kurata Y, Shiota G, Narahashi T, Horiuchi M, Matsubara H, Ninomiya H, Hisatome I. Sonoyama K, et al. Among authors: yamamoto y. Hypertens Res. 2005 Feb;28(2):173-9. doi: 10.1291/hypres.28.173. Hypertens Res. 2005. PMID: 16025745
12,311 results
You have reached the last available page of results. Please see the User Guide for more information.